ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,796.00
0.34%
S&P ASX All Technology
3,092.40
0.70%
Brent Oil
84.39
0.00%
US Dollar vs AUD
1.49678
0.00%
Bitcoin
64,346.89
0.16%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Surrozen Inc (SRZN)

  7. Surrozen Inc (SRZN) News

SRZN

Surrozen (SRZN)

Surrozen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SRZN
DateTimeSourceHeadlineSymbolCompany
12/06/202422:30GlobeNewswire Inc.Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt SignalingNASDAQ:SRZNSurrozen Inc
10/06/202422:30GlobeNewswire Inc.Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in MilanNASDAQ:SRZNSurrozen Inc
04/06/202422:30GlobeNewswire Inc.Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated HepatitisNASDAQ:SRZNSurrozen Inc
09/05/202422:30GlobeNewswire Inc.Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual MeetingNASDAQ:SRZNSurrozen Inc
09/05/202406:05GlobeNewswire Inc.Surrozen Provides First Quarter 2024 Financial Results and Business UpdateNASDAQ:SRZNSurrozen Inc
03/04/202423:40GlobeNewswire Inc.Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary FibrosisNASDAQ:SRZNSurrozen Inc
01/04/202423:30GlobeNewswire Inc.Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043NASDAQ:SRZNSurrozen Inc
01/04/202423:30GlobeNewswire Inc.Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq RulesNASDAQ:SRZNSurrozen Inc
07/02/202422:16Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
07/02/202422:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
23/01/202409:24Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
19/01/202400:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
19/01/202400:30GlobeNewswire Inc.Surrozen Provides Corporate Update on Clinical ProgramsNASDAQ:SRZNSurrozen Inc
19/12/202313:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SRZNSurrozen Inc
14/12/202309:21Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
14/12/202309:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
12/12/202308:11Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
12/12/202308:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
09/11/202308:27Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
09/11/202308:17Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRZNSurrozen Inc
09/11/202308:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
09/11/202308:05GlobeNewswire Inc.Surrozen Provides Third Quarter 2023 Financial ResultsNASDAQ:SRZNSurrozen Inc
25/10/202307:23Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SRZNSurrozen Inc
25/10/202307:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SRZNSurrozen Inc
14/10/202307:51Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SRZNSurrozen Inc
14/10/202307:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
24/08/202307:17Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SRZNSurrozen Inc
10/08/202306:39Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SRZNSurrozen Inc
10/08/202306:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SRZNSurrozen Inc
10/08/202306:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SRZNSurrozen Inc
 Showing the most relevant articles for your search:NASDAQ:SRZN

Your Recent History

USOTC
FHSEY
First HighSchool Education (QB)
EU
VDMAG
Ville de Marseille 1.599...
NASDAQ
ANSCU
Agriculture and Natural ...
TSXV
BMEX
BMEX Gold
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved